Latest Us Expansion News

Page 2 of 32
RMA Global delivered positive underlying EBITDA of A$0.12 million in the first quarter of FY27, despite weaker customer receipts and revenue. More than A$1.50 million in annualised costs has been removed, but cash of A$1.66 million leaves limited room for execution missteps.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Knosys has moved its Libero library platform into active US commercialisation, identifying near-term sales opportunities while preparing for its first customer engagements. The push comes as ARR slips to A$8.7 million and a timing-affected quarter leaves the company with 2.03 quarters of estimated funding.
Victor Sage
Victor Sage
29 Oct 2026
AVA Risk Group has opened FY27 with A$6.7 million in quarterly bookings and a 1.2 book-to-bill ratio, while acknowledging that FY26 revenue and profitability fell short of expectations. The company is betting that sharper commercial discipline, US expansion and a broader solutions model can turn a large pipeline into more dependable growth.
Victor Sage
Victor Sage
29 Oct 2026
Cyclopharm has reported record third-quarter US Technegas revenue of A$1.62 million, with 76% generated by recurring consumable orders. Its installed base and hospital pipeline expanded sharply after new clinical guidelines preferred Technegas when available, while quarterly cash burn fell to A$0.9 million.
Ada Torres
Ada Torres
29 Oct 2026
Bubs Australia has expanded its US footprint to more than 12,000 stores after securing permanent FDA authorisation, but quarterly revenue fell 9.8% and operating cash outflow increased. The company ended September with A$13.4 million of available liquidity, equivalent to 2.2 quarters at the reported cash-burn rate.
Victor Sage
Victor Sage
29 Oct 2026
Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.
Victor Sage
Victor Sage
28 Oct 2026
Singular Health has moved closer to a proposed A$3.5 million Florida Medicaid imaging repository while deploying 1,000 physician licences through its largest customer network. The September quarter also exposed the execution risks ahead, with the Florida MOU still subject to definitive agreements and the PNS contract due for renewal by year-end.
Victor Sage
Victor Sage
27 Oct 2026
Nova Eye Medical delivered 30% year-on-year sales growth in the September quarter, alongside positive operating cash flow and EBITDA. The company confirmed FY27 guidance, but is still seeking to replace a related-party funding facility carrying 15% interest.
Victor Sage
Victor Sage
27 Oct 2026
Janus Electric has secured a repeat A$3.1 million order from California operator King Fio Trucking, lifting its North American order book to 124 trucks. The expansion reuses existing charging and battery-swapping infrastructure, but remains conditional on California incentive approval.
Victor Sage
Victor Sage
27 Oct 2026
Janus Electric has signed a non-binding MOU with ConGlobal for a proposed 20-truck Class 8 conversion pilot in Texas. A successful pilot could open a pathway to conversion, battery-swapping and servicing operations across ConGlobal’s 31 US depots, although no binding orders or commercial terms have been agreed.
Victor Sage
Victor Sage
26 Oct 2026
Echo IQ’s FDA-cleared EchoSolv AS platform processed 9,697 full-result assessments in the September quarter, while the company ended the period with A$107.8 million in cash. The stronger balance sheet gives it room to pursue US enterprise deployments, but commercial conversion and the unresolved EchoSolv HF regulatory pathway remain the key tests.
Victor Sage
Victor Sage
26 Oct 2026
Carnegie Clean Energy has moved its flagship CETO wave-energy project towards offshore deployment in Spain, but the technology developer ended 2026 with a wider loss, $996,347 in cash and a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
23 Oct 2026

Browse the archive

Full archive